1·Gastric carcinoma closely relates with intestinal metaplasia.
胃癌与肠化生关系密切。
2·Chronic gastritis with intestinal metaplasia, negative for dysplasia or malignancy.
慢性胃炎伴肠化，无异型增生或恶性肿瘤。
3·Usually it arises in a background of chronic atrophic gastritis with intestinal metaplasia.
背景通常为慢性萎缩性胃炎伴肠化。
4·Some gastric cancer patients did not undergo intestinal metaplasia or gastric mucosa dysplasia.
胃癌中部分患者并不经历肠上皮化生或异型增生阶段。
5·Beyond the well known intestinal metaplasia and chronic gastritis, we found also other atypia or dysplasia.
作者认为，除注意肠上皮化生和萎缩性胃炎等表现外，各种不典型增生现象也很重要。
6·Yet is the premalignant lesion the readily recognized intestinal metaplasia or the more difficult to detect dysplasia?
然而癌前病变是已经公认的肠化生还是更难于探及的不典型增生。
7·Gastric intestinal metaplasia is a common finding in countries with a high prevalence of Helicobacter pylori infection.
胃的肠化生在幽门螺杆菌高感染率的国家普遍存在。
8·Liver cell is the metabolic one of intestinal metaplasia, it functions to transport and digest, should belong to spleen.
肝细胞是肠上皮特化的代谢细胞，其功能主运化，当归属脾藏。
9·The problem is the low prevalence of the premalignant lesion being assessed (ie, dysplasia in gastric intestinal metaplasia).
该问题是评估低流行癌前病变(如，胃肠化生中的非典型增生)。
10·Is the premalignant lesion to be detected the readily recognized intestinal metaplasia or the more difficult to detect dysplasia?
公认的肠化生或更难发现的异型增生是否做为癌前病变得到检测？